Spinal Tech

Smith & Nephew stock prices have been up nearly 25 percent this year, solidifying the orthopedic implant maker's economic recovery and leading the way to further hip and knee market growth, according to a report in The Wall Street Journal.

Israel-based Mazor Robotics sold a Renaissance spine system to a hospital in the southeastern U.S. that provides integrated care from birth to hospice.

Boston Scientific announced that new retrospective data has been released demonstrating that its Precision Spectra Spinal Cord Stimulator System provided significant pain relief three months after implantation.

Blue M Medical, a manufacturer of custom medical devices, announced that the company will soon launch its operations in Columbia City, Ind., according to an Inside INdiana Business report.

Santa Rosa, Calif.-based Osseon Therapeutics announced the appointment of Gary Hogman as regional sales director.

Maetta Sciences announced that it has received FDA clearance for a cobalt chrome orthopedic implantable device manufactured using its proprietary metal injection molding technology.

The orthopedic devices market is expected to reach $19.2 billion by 2016 at a compound annual growth rate of 5.8 percent from 2011 to 2016, according to report released by MarketsandMarkets, a market research and consulting company.

The Food and Drug Administration has granted 19 spine-related device clearances in November.

TYRX announced that it has received FDA clearance for marketing the AIGISRx N Antibacterial Envelope for use with spinal cord neuromodulators.

Aurora Spine has been granted FDA 510(k) clearance for its ZIP minimally invasive interspinous fusion system.